中药调节IL-23/Th17通路防治银屑病的研究进展
Research Progress on the Regulation of IL-23/Th17 Pathway by Traditional Chinese Medicine in the Prevention and Treatment of Psoriasis
摘要: 银屑病是一种常见的慢性炎症性皮肤病。根据流行病学调查显示，其患病率呈上升趋势。白细胞介素23 (IL-23)/辅助性T细胞17 (Th17)通路在银屑病发病中起重要作用，目前被广泛用于银屑病的研究。大量的分子生物学实验表明，中药单体或有效成分、中药复方可通过调节IL-23/Th17通路，影响相关细胞因子和转录因子，以达到减轻银屑病炎症反应、恢复正常机体免疫功能。综述近年来中药单体及中药复方通过调节IL-23/Th17通路治疗银屑病的相关研究成果，以期为中药研发及临床防治提供新的思路。
Abstract: Psoriasis is a common chronic inflammatory skin disease. According to the epidemiological survey, its prevalence is on the rise. The interleukin-23 (IL-23)/Helper T cell 17 (Th17) pathway plays an important role in the pathogenesis of psoriasis and is widely used in the study of psoriasis. A large number of molecular biology experiments have shown that TCM monomeric or active components and TCM compounds can affect related cytokines and transcription factors by regulating IL-23/Th17 pathway, so as to reduce inflammation in psoriasis and restore normal immune func-tion. In order to provide new ideas for TCM research and development, clinical prevention and treatment, the recent research results of TCM monomer and TCM compound in the treatment of psoriasis by regulating IL-23/Th17 pathway were reviewed.
文章引用：周义. 中药调节IL-23/Th17通路防治银屑病的研究进展[J]. 临床医学进展, 2023, 13(7): 10943-10948. https://doi.org/10.12677/ACM.2023.1371528

参考文献

[1] 张学军. 皮肤性病学[M]. 第9版. 北京: 人民卫生出版社, 2018: 133-134.
[2] 全国银屑病流行调查组, 邵长庚, 张国威, 包寅德, 蒋仲元, 韩国柱, 顾恒. 全国1984年银屑病流行调查报告[J]. 皮肤病与性病, 1989(1): 60-72.
[3] Ding, X., Wang, T., Shen, Y., et al. (2012) Prevalence of Psoriasis in China: A Population-Based Study in Six Cities. European Journal of Dermatology, 22, 663-667. [Google Scholar] [CrossRef] [PubMed]
[4] Deng, Y., Chang, C. and Lu, Q. (2016) The Inflammatory Response in Psoriasis: A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 50, 377-389. [Google Scholar] [CrossRef] [PubMed]
[5] 林立, 王姗姗, 杨素清. 中药调节银屑病相关分子研究进展[J]. 中国中医药信息杂志, 2022, 29(5): 147-152. [Google Scholar] [CrossRef] 
[6] 朱雨雨, 宋承霖, 孙洋. 银屑病发病机制及药物调控研究进展[J]. 药学学报, 2020, 55(7): 1393-1400. [Google Scholar] [CrossRef] 
[7] Oppmann, B., Lesley, R., Blom, B., et al. (2000) Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12. Immunity, 13, 715-725. [Google Scholar] [CrossRef] 
[8] Haniffa, M., Gunawan, M. and Jardine, L. (2015) Human Skin Dendritic Cells in Health and Disease. Journal of Dermatological Science, 77, 85-92. [Google Scholar] [CrossRef] [PubMed]
[9] Bloch, Y., Bouchareychas, L., Merceron, R., et al. (2018) Structural Activation of Pro-Inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1. Immunity, 48, 45-58.e6. [Google Scholar] [CrossRef] [PubMed]
[10] Gooderham, M.J., Papp, K.A. and Lynde, C.W. (2018) Shifting the Focus—The Primary Role of IL-23 in Psoriasis and Other Inflammatory Disorders. Journal of the European Acade-my of Dermatology and Venereology, 32, 1111-1119. [Google Scholar] [CrossRef] [PubMed]
[11] 李清林, 章煌杰, 葛明华, 等. 基于Th17/Treg平衡和IL-23/IL-17炎症轴探讨淫羊藿总黄酮防治桥本甲状腺炎的作用机制[J]. 中华中医药学刊, 2021, 39(8): 71-77+266-267. [Google Scholar] [CrossRef] 
[12] 王宁, 张卫宁, 陈雨婕, 等. IL-23/IL-17炎症轴与炎症性肠病的关系研究进展[J]. 细胞与分子免疫学杂志, 2021, 37(3): 271-277. [Google Scholar] [CrossRef] 
[13] Hou, Y., Zhu, L., Tian, H., et al. (2018) IL-23-Induced Macro-phage Polarization and Its Pathological Roles in Mice with Imiquimod-Induced Psoriasis. Protein & Cell, 9, 1027-1038. [Google Scholar] [CrossRef] [PubMed]
[14] Martin, D.A., Towne, J.E., Kricorian, G., et al. (2013) The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings. Journal of Investigative Dermatology, 133, 17-26. [Google Scholar] [CrossRef] [PubMed]
[15] Cătană, C.S., Berindan Neagoe, I., Cozma, V., Magdaş, C., Tăbăran, F. and Dumitraşcu, D.L. (2015) Contribution of the IL-17/IL-23 Axis to the Pathogenesis of Inflammatory Bowel Disease. World Journal of Gastroenterology, 21, 5823-5830. [Google Scholar] [CrossRef] [PubMed]
[16] Fitch, E., Har-per, E., Skorcheva, I., Kurtz, S.E. and Blauvelt, A. (2007) Pathophysiology of Psoriasis: Recent Advances on IL-23 and Th17 Cytokines. Current Rheumatology Reports, 9, 461-467. [Google Scholar] [CrossRef] [PubMed]
[17] Lowes, M.A., Russell, C.B., Martin, D.A., Towne, J.E. and Krueger, J.G. (2013) The IL-23/T17 Pathogenic Axis in Psoriasis Is Amplified by Keratinocyte Responses. Trends in Immunology, 34, 174-181. [Google Scholar] [CrossRef] [PubMed]
[18] Tonel, G. and Conrad, C. (2009) Interplay between Keratinocytes and Immune Cells—Recent Insights into Psoriasis Pathogenesis. The International Journal of Biochemistry & Cell Biology, 41, 963-968. [Google Scholar] [CrossRef] [PubMed]
[19] Yawalkar, N., Karlen, S., Hunger, R., Brand, C.U. and Braathen, L.R. (1998) Expression of Interleukin-12 Is Increased in Psoriatic Skin. Journal of Investigative Dermatology, 111, 1053-1057. [Google Scholar] [CrossRef] [PubMed]
[20] 张伟晴, 沙日耐, 姜萱璟, 等. 银屑病免疫治疗靶点研究进展[J]. 基因组学与应用生物学, 2021, 40(Z4): 3853- 3862. [Google Scholar] [CrossRef] 
[21] Lee, E., Trepicchio, W.L., Oestreicher, J.L., et al. (2004) Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris. Journal of Experimental Medicine, 199, 125-130. [Google Scholar] [CrossRef] [PubMed]
[22] Kastelein, R.A., Hunter, C.A. and Cua, D.J. (2007) Discovery and Bi-ology of IL-23 and IL-27: Related but Functionally Distinct Regulators of Inflammation. Annual Review of Immunology, 25, 221-242. [Google Scholar] [CrossRef] [PubMed]
[23] 乔菊, 高祎濛, 李峰, 等. 银屑病患者外周血TNF-α、IL-17A、IL-23、IL-36γ表达水平及临床意义[J]. 中国皮肤性病学杂志, 2019, 33(3): 280-284. [Google Scholar] [CrossRef] 
[24] 赵京霞, 底婷婷, 王燕, 等. IL-23/IL-17炎症轴在咪喹莫特诱导的小鼠银屑病样皮肤损害中的作用[J]. 中国病理生理杂志, 2013, 29(6): 1086-1094.
[25] 马彦巧, 陈积, 李磊, 等. 白细胞介素-23抑制剂治疗银屑病的研究进展[J]. 中国新药杂志, 2018, 27(8): 899-904.
[26] 刘小扬, 蔡林, 张建中. 白细胞介素-17抑制剂治疗银屑病的效能及应用[J]. 临床皮肤科杂志, 2021, 50(3): 173-177. [Google Scholar] [CrossRef] 
[27] 李明洙, 钟伟章. 白细胞介素(IL)-12/23、IL-17和IL-23抑制剂治疗中度至重度斑块状银屑病的疗效和安全性的系统评价[J]. 临床皮肤科杂志, 2022, 51(1): 11-18. [Google Scholar] [CrossRef] 
[28] 吴先伟, 邓秀娥, 汪舰笛, 等. 白芍总苷对老年中重度斑块状银屑病患者T淋巴细胞亚群及相关细胞因子的影响[J]. 中国中西医结合皮肤性病学杂志, 2022, 21(4): 310-313.
[29] Gaelle, E.T.T., 江从军. 雷公藤多苷对寻常型银屑病患者外周血Th17/Treg相关细胞因子的影响[J]. 中华全科医学, 2019, 17(8): 1272-1274. [Google Scholar] [CrossRef] 
[30] 行敏, 任宏伟, 屈慧明, 等. 寻常型银屑病患者血清中IL-17的表达及紫草素对IL-17刺激HaCaT细胞分泌IL-6和IL-23的影响[J]. 吉林大学学报(医学版), 2017, 43(5): 958-962. [Google Scholar] [CrossRef] 
[31] 王雾, 杨梅, 蒋梦雅, 等. 人参皂苷CK对咪喹莫特诱导小鼠银屑病的治疗作用[J]. 中国药理学通报, 2021, 37(1): 31-37.
[32] 孙丹, 闫小宁, 耿蒙利, 等. 银屑平片对咪喹莫特诱导银屑病样模型小鼠IL-17、IL-23、PPARγ表达的影响[J]. 中国中医药信息杂志, 2022, 29(4): 64-68. [Google Scholar] [CrossRef] 
[33] 钟淇滨, 祝曙光, 陆少君, 等. 和厚朴酚对咪喹莫特诱导小鼠银屑病的干预作用[J]. 中国药理学通报, 2018, 34(5): 626-631.
[34] 周海锋. 苦豆碱通过调控IL-23/Th17轴和促进Treg稳定性缓解IMQ诱导的小鼠银屑病样皮炎[D]: [硕士学位论文]. 武汉: 华中科技大学, 2019.[CrossRef] 
[35] 热比姑丽•伊斯拉木, 艾西木江•热甫卡提, 阿布都吉力力•阿布都艾尼, 等. 土大黄对银屑病小鼠皮肤组织转化生长因子-β1及神经纤维蛋白-1表达的影响[J]. 中国药业, 2020, 29(3): 20-24.
[36] 李皓月, 李超然, 王远红, 等. 银屑病中医文献简述[J]. 中国中医基础医学杂志, 2019, 25(9): 1331-1334. [Google Scholar] [CrossRef] 
[37] 王丽, 方玉甫, 周国秀, 等. 基于IL-23/Th17探讨清营汤治疗银屑病血热证的临床疗效及作用机制[J]. 中国中药杂志, 2019, 44(1): 175-180. [Google Scholar] [CrossRef] [PubMed]
[38] 李红, 李珺莹, 吉彬, 等. 清热解毒汤治疗血热型寻常型银屑病及对Th17轴的影响[J]. 中国中西医结合皮肤性病学杂志, 2019, 18(1): 56-58.
[39] 杨登科. 基于IL-23/Th17免疫炎症轴探讨加味净屑饮治疗银屑病的临床疗效及免疫学机制[D]: [博士学位论文]. 南京: 南京中医药大学, 2021.[CrossRef] 
[40] 张绚辉, 张玲, 曾海燕, 等. 重楼凉血克银方内服和外用对银屑病血热风盛证患者IL-23/IL-17轴的调节作用[J]. 环球中医药, 2020, 13(12): 2167-2169.
[41] 安月鹏, 闫景东, 杨素清. 蜈蚣败毒饮对银屑病小鼠皮损中Th17细胞主导通路相关因子基因表达影响的实验研究[J]. 时珍国医国药, 2020, 31(7): 1556-1559.
[42] 杨素清, 安月鹏. 蜈蚣败毒饮对银屑病转基因模型小鼠外周血中Th17细胞表达影响的研究[J]. 中国中西医结合皮肤性病学杂志, 2017, 16(6): 481-484.
[43] 安月鹏, 柏青松, 袁锐, 等. 蜈蚣败毒饮对转基因银屑病模型皮损IL-17和IL-23蛋白表达的影响及与皮损指数的相关性[J]. 中国皮肤性病学杂志, 2019, 33(5): 575-579. [Google Scholar] [CrossRef] 
[44] 黄港, 龚丽萍, 邱桂荣, 等. 透表和营解毒汤治疗银屑病小鼠模型的实验研究[J]. 时珍国医国药, 2020, 31(8): 1837-1840.
[45] 黄港, 龚丽萍, 邱桂荣, 等. 透表和营解毒方治疗血热型银屑病的临床研究[J]. 南京中医药大学学报, 2019, 35(4): 399-402. [Google Scholar] [CrossRef] 
[46] 张朋月, 杨波, 李咏梅, 等. 泻肝凉血解毒方对豚鼠银屑病模型IL-23/Th17轴的调节作用[J]. 中华中医药杂志, 2017, 32(7): 3217-3220.
[47] 李宁飞, 王燕, 赵京霞, 等. 活血解毒方对银屑病小鼠血管增殖以及炎症因子的干预作用[J]. 北京中医药大学学报, 2019, 42(4): 296-303.

为你推荐